S Science Co Operating Expenses
The Total Operating Expenses of S Science Co (5721.T) as of Oct 11, 2026 is 706.19 M JPY. In the previous year, Total Operating Expenses was 93.12 M JPY — a change of 658.38% (higher).
Get this data via API
Financial Data API
Operating Expenses
706.19 MJPY
YoY
658.38%
Last updated:
The S Science Co Operating Expenses history
3 Years
10 Years
25 Years
Max
| YEAR | Operating Expenses | YoY |
|---|---|---|
| 706.19 MJPY | +658.38% | |
| 93.12 MJPY | +74.29% | |
| 53.43 MJPY | -10.95% | |
| 60.00 MJPY | +11.11% | |
| 54.00 MJPY | +395.87% | |
| 10.89 MJPY | -96.05% | |
| 275.96 MJPY | +0.13% | |
| 275.60 MJPY | +0.10% | |
| 275.32 MJPY | +4.44% | |
| 263.62 MJPY | -3.11% | |
| 272.07 MJPY | +2.32% | |
| 265.90 MJPY | -10.37% | |
| 296.65 MJPY | — |
S Science Co Stock analysis
Frequently Asked Questions about S Science Co stock
Total Operating Expenses of S Science Co is 706.19 M JPY in 2026.
Total Operating Expenses of S Science Co changed from 93.12 M JPY to 706.19 M JPY, representing a 658.38% change. The value is higher than the previous year.
On Eulerpool you can find the complete historical development of Total Operating Expenses S Science Co since 2006 – with annual values, charts, and detailed analysis.
Operating expenses are the costs incurred in the normal course of business operations, including COGS, SG&A, R&D, and depreciation.
Total Operating Expenses's JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Total Operating Expenses's S Science Co historically and in real time.
Income Statement — S Science Co
All Key Metrics — S Science Co
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth